Presidential election creates Central Coast winners and losers
After euphoria comes reality. The stock market rally that accompanied the election of Donald J. Trump as the nation’s 45th president has flattened out amid the reality that governing is complex and so is the economy. With Trump’s election, the slow growth predictability of the Obama years has been replaced with something new. But aside Read More →
Aerial Alchemy takes on challenge of managing drone data
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s Humira biosimilar delayed, Enbrel approved
Amgen’s Humira biosimilar Amjevita will be delayed at least through 2017 due to litigation by competitor AbbVie. The maker of Humira filed a patent infringement claim against Amgen on Aug. 4, alleging that the drug also violates the Biosimilar Price Competition and Innovation Act. Amgen was approved to market its biosimilar Sept. 23 by the Read More →
Joens: A fond farewell to the tri-county technology scene
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inphi tops expectations for third quarter
Inphi beat Wall Street expectations on revenue in its third quarter earnings report. The Thousand Oaks semiconductor design company reported $70.7 million in revenue on a U.S. generally accepted accounting principles (GAAP) basis, exceeding projections of $67.9 million. That was up 49 percent from $47.4 million in the third quarter of 2015. The growth of Read More →
Teledyne sales dip but profits up for third quarter
Thousand Oaks-based industrial conglomerate Teledyne Technologies saw sales dip but profits increase during the third quarter, according to figures released Nov. 3. Revenues for the company dipped to $526.8 million in the third quarter, compared to $551.7 during the third quarter of 2015. That missed analyst revenue estimates of $553 million, according to S&P Capital Read More →
Thousand Oaks property will become medical clinic
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
